Detecting lung issues in rheumatoid arthritis patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop a standardized screening protocol to detect pleuropulmonary manifestations in patients with rheumatoid arthritis. It will involve comprehensive clinical evaluations, laboratory tests, and lung function assessments, all correlated with structural lung assessments using computed tomography (CT). A machine learning-based risk-modeling approach will be employed to create a screening tool, which will later be made available as an online tool and mobile app for external validation and clinical application.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
* Residence in Austria
* Signed and dated consent of the patient in accordance with ICH-GCP guidelines

Exclusion Criteria:

* pregnancy
* age below 18 years
* Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)

Where it's running

• Medical University Innsbruck
  Innsbruck, Austria, Austria Recruiting

Study contacts

• Study coordinator: Thomas Sonnweber, MD, PhD
• Email: Thomas.Sonnweber@i-med.ac.at
• Phone: +43(0)51250482586

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Support program for partners and informal caregivers of frail older adults with rheumatoid arthritis

  This project tests a tailored, 12-week support program for unpaid caregivers of older adults (65+) with rheumatoid arthritis and frailty to reduce caregiver burden and help navigate care.

  Recruiting Glostrup University Hospital, Copenhagen · Glostrup Municipality, Capital Region · NCT07442773

• Resveratrol added to usual treatment for moderate-to-high rheumatoid arthritis

  This will see if giving adults with moderate-to-high rheumatoid arthritis 1 g of resveratrol daily alongside their usual medicines for three months reduces inflammation, disease activity, and improves quality of life.

  Recruiting Ain Shams University · Cairo · NCT07089381

• Identifying biomarkers for early diagnosis of inflammatory rheumatic diseases

  This study is trying to find specific markers in the body that can help doctors diagnose inflammatory rheumatic diseases like Ankylosing Spondylitis, Rheumatoid Arthritis, and Systemic Lupus Erythematosus earlier and more accurately.

  Recruiting Universidade Nova de Lisboa · Lisbon · NCT06778343

• A platform for collecting health data on ME/CFS and Long Covid

  This study is trying to collect health information from adults with ME/CFS and Long Covid to help researchers better understand these conditions and improve future treatments.

  Recruiting Brain Inflammation Collaborative · Delafield, Wisconsin · NCT04806620

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.